Crinetics Pharmaceuticals Inc CRNX
News
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Crinetics Launches ACRO/TRUTH Educational Initiative to Raise Awareness of Acromegaly Treatment Challenges
Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tesla and Canopy Growth stocks surge, RTX and J.M. Smucker shares fall, and other stocks on the move
Crinetics Pharmaceuticals shares surge 65%, analysts raise price target after acromegaly treatment results